创新医疗(002173.SZ)：2025年中报净利润为-1136.13万元

Core Insights - The company reported a total revenue of 402 million yuan for the first half of 2025, a decrease of 6.51 million yuan compared to the same period last year, representing a year-on-year decline of 1.60% [1] - The net profit attributable to shareholders was -11.36 million yuan, indicating a loss [1] - The net cash inflow from operating activities was 83.72 million yuan [1] Financial Metrics - The latest debt-to-asset ratio is 18.03%, an increase of 0.75 percentage points from the same period last year [3] - The latest gross profit margin stands at 12.06% [3] - The return on equity (ROE) is -0.64% [3] - The diluted earnings per share (EPS) is -0.03 yuan [3] - The total asset turnover ratio is 0.18 times [3] - The inventory turnover ratio is 9.84 times [3] Shareholder Information - The number of shareholders is 82,000, with the top ten shareholders holding a total of 152 million shares, accounting for 34.46% of the total share capital [3] - The top ten shareholders and their holdings are as follows: - Chen Xiaying: 17.5 million shares - Chen Haijun: 5.04 million shares - Shanghai Guanghuan Technology Co., Ltd.: 4.97 million shares - Hangzhou Changjian Investment Partnership (Limited Partnership): 2.73 million shares - Han Meng: 1.02 million shares - Ma Jianjian: 0.72 million shares - Barclays Bank PLC: 0.66 million shares - Goldman Sachs International - Proprietary Funds: 0.64 million shares - Miao Ping: 0.60 million shares - Zhong Linduo: 0.49 million shares [3]